The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ierino, F. L.
Right arrow Articles by Sachs, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ierino, F. L.
Right arrow Articles by Sachs, D. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Kidney Transplantation
The Journal of Immunology, 1999, 162: 550-559.
Copyright © 1999 by The American Association of Immunologists

Peripheral Tolerance to Class I Mismatched Renal Allografts in Miniature Swine: Donor Antigen-Activated Peripheral Blood Lymphocytes from Tolerant Swine Inhibit Antidonor CTL Reactivity1

Francesco L. Ierino2, Kazuhiko Yamada, Tevis Hatch, James Rembert and David H. Sachs3

Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Studies utilizing partially inbred miniature swine have demonstrated that a short course of cyclosporin A leads to indefinite survival of two haplotype class I mismatched renal allografts. In the present study, we have examined peripheral regulatory mechanisms that may be involved in maintenance of tolerance by coculturing PBL from long-term tolerant animals with naive recipient-matched PBL in cell-mediated lympholysis assays. We show that PBL from tolerant animals, primed in vitro with donor Ag, suppress antidonor CTL reactivity by naive recipient-matched PBL. Suppression was not observed when PBL from naive animals, primed with donor-matched PBL, were cocultured with PBL from a second naive animal, nor did PBL from either tolerant or naive recipient-matched control animals, primed with third-party Ag, suppress the generation of anti-third-party CTL by a second naive animal. The suppression was cell dose-dependent, radiation-sensitive, required cell-to-cell contact not reversed by the provision of exogenous IL-2, and associated with lower levels of IL-2R expression on the suppressive effector group (particularly the CD8 single positive cells) when compared with the control effector group. These data indicate an association between the presence of peripheral regulatory cells demonstrable in vitro and the maintenance of tolerance to renal allografts.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The induction and maintenance of tolerance to allografts and self Ags may be achieved by mechanisms that develop within the thymus or among mature T cells in the extrathymic environment (1). The T cell mechanisms that have been described include clonal deletion (2, 3, 4), anergy (5, 6, 7, 8), immune suppression (8, 9, 10, 11, 12, 13, 14, 15, 16), veto cell activity (17, 18), and T cell ignorance of alloantigen (19), none of which are mutually exclusive. Our laboratory has utilized partially inbred miniature swine with well-defined MHC loci (SLA)4 (20) as a preclinical model to study the biology of transplantation tolerance in a large animal model (21, 22).

Extensive studies are in progress to determine the mechanisms by which long-term acceptance of two haplotype class I mismatched renal allografts is achieved following a 12-day course of cyclosporin A (CyA; 23 . Graft acceptance is associated with a specific deficiency of antidonor class I T cell help during the induction and maintenance of tolerance (23, 24, 55). Studies have also indicated that tolerance is systemic since a second renal allograft, SLA-matched to the original donor, is accepted without further immunosuppression if retransplanted at the time of graftectomy (25). Recent studies have demonstrated that tolerance involves both thymus-dependent and peripheral mechanisms (26). The thymus is required for the induction of stable tolerance, since animals thymectomized (thyx) before transplantation undergo acute cellular rejection after CyA therapy is discontinued. However, in some thymectomized animals, rejection subsides spontaneously and recipients maintain the renal allografts long-term, indicating that peripheral mechanisms of tolerance can also lead to graft acceptance (26). Analysis of cytokine gene expression in renal allografts demonstrated a correlation between graft acceptance and a differential cytokine production consistent with a shift toward a Th2 response (27, 28). Kidney biopsies collected from tolerant animals demonstrated high levels of IL-10 gene expression but low levels of IFN-{gamma} gene activation. In contrast, biopsies from rejecting animals demonstrated marked up-regulation of the IFN-{gamma} gene. These results suggested that local production of regulatory cytokines may be involved in the mechanism of tolerance to renal allografts.

Although peripheral T cell tolerance has been described in many systems (1, 21, 29), definitive information regarding cellular mechanisms responsible for the development of graft tolerance remains incomplete. Therefore, studies of peripheral tolerance in a preclinical large animal model may help to elucidate such mechanisms and extend these findings to clinical transplantation. The present report demonstrates that PBL from tolerant animals primed in vitro with donor Ag suppress the generation of antidonor CTL reactivity by naive recipient-matched PBL. The studies suggest that regulatory cells demonstrable in vitro may be involved in the maintenance of tolerance.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

The surgical procedures, clinical course, and immunogenetic characteristics of the miniature swine used in this study have been described in detail elsewhere (Refs. 20, 23, and 26; Yamada et al., manuscript in preparation). Animals received two haplotype class I mismatched renal allografts (SLAgg (class Ic, class IId) donor->SLAdd (class Id, class IId) recipient) and were treated with a 12-day course of CyA. In addition, the animals were either nonthymectomized (nos. 11468, 12019, and 11609) or thymectomized (nos. 11446, 11384, and 11207). The swine were thymectomized on day -42 (nos. 11446 and 11384) or day 0 (no. 11207), in relation to the day of renal transplantation. Both thymectomized and nonthymectomized swine (hereafter referred to as thyxtolerant-to-G swine and non-thyxtolerant-to-G swine, respectively) accepted their SLAgg renal allografts long-term (>90 days). Two naive SLAdd swine (nos. 10785 and 10466) were used as control animals.

Medium

Tissue culture medium used for cell-mediated lympholysis (CML) assays consisted of RPMI 1640 (Life Technologies, Gaithersburg, MD) supplemented with 6% FCS (Sigma, St. Louis, MO), 100 U/ml of penicillin and 135 µg/ml of streptomycin (Life Technologies), 50 µg/ml of gentamicin (Life Technologies), 10 mM of HEPES (Fisher Scientific, Pittsburgh, PA), 2 mM of L-glutamine (Life Technologies), 1 mM of sodium pyruvate (BioWhittaker, Walkersville, MD), 0.1 mM of nonessential amino acids (BioWhittaker), and 5 x 10-5 M of 2-ME (Sigma). The effector phase of the CML assay was performed using Eagle’s basal medium (Life Technologies) supplemented with 6% controlled processed serum replacement-3 (Sigma) and 10 mM of HEPES (Fisher Scientific).

Isolation of PBL

Heparinized whole blood was diluted ~1:2 with HBSS (Life Technologies), and the mononuclear cells were obtained by gradient centrifugation using lymphocyte separation medium (Organon Teknika, Durham, NC). The mononuclear cells were washed once with HBSS, and contaminating red cells were lysed with ammonium chloride potassium buffer (B&B Research Laboratory, Fiskeville, RI). Cells were then washed with HBSS resuspended in tissue culture medium and kept at 4°C until used in cellular assays or flow cytometry studies.

CML assays

Four types of CML assay systems were used in these studies.

Primary CML assays. Lymphocyte cultures containing 2 x 106 responder cells (PBL from naive SLAdd, nonthymectomized or thymectomized animals) and 4 x 106 stimulator PBL (SLAgg or third-party PBL, irradiated with 25 Gy) per well in a final volume of 2 ml of medium were incubated for 6 days at 37°C in 7.5% CO2 using 24-well flat-bottom plates (Costar, Cambridge, MA). Bulk cultures were harvested, and effectors were tested for cytotoxic activity on target lymphocytes stimulated by phytohemagglutinin (M-Form, Life Technologies) previously titrated to give optimal proliferation. Target cells were labeled with 51Cr (Amersham, Arlington Heights, IL) and incubated with the effector groups for 5.5 h using a negative control target (SLA-matched to the responders, i.e., SLAdd) and targets SLA-matched to the stimulators, which included donor-matched PBL (SLAgg: class Icc and class IIdd) and third-party stimulators (SLAhh: class Iaa and class IIdd; or SLAaa: class Iaa and class IIaa). E:T ratios of 100:1, 50:1, 25:1, and 12.5:1 were tested. Supernatants were harvested using the Skatron collection system (Skatron, Sterling, VA), and 51Cr release was determined on a gamma counter (Micromedics, Huntsville, AL). The results were expressed as percent specific lysis (PSL) and calculated as: PSL = {[experimental release (cpm) - spontaneous release (cpm)]/[maximum release (cpm) - spontaneous release (cpm)]} x 100%.

Primary CML coculture assays. Control MLC were prepared using 24-well flat-bottom plates (Costar), each well containing 2 x 106 naive SLAdd responder PBL (naive1) and 4 x 106 stimulator PBL (irradiated with 25 Gy) in a final volume of 2 ml of medium. The same source of naive SLAdd-responder PBL were used as indicator cells to detect suppression by PBL from tolerant animals in coculture assays. Similar MLC were prepared using PBL from tolerant SLAdd animals (nonthymectomized or thymectomized). Stimulator cells were donor-matched PBL (SLAgg) or third-party PBL (SLAhh or SLAaa). Cocultures contained 2 x 106 naive SLAdd-responder PBL, 2 x 106 PBL from tolerant animals, and 4 x 106 irradiated stimulator PBL per well in a final volume of 2 ml of medium. Additional cultures containing 4 x 106 responder PBL and 4 x 106 irradiated stimulator PBL were performed for naive and tolerant responder PBL to control for crowding effects due to increased numbers in the cocultures. Cultures were incubated for 6 days at 37°C in 7.5% CO2 and harvested, and effectors were tested for cytotoxic activity as described above.

Secondary coculture assays. These assays were performed in two sequential phases (Fig. 1Go).



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 1. Schematic diagram of phase 1 and phase 2 of the secondary coculture assays for PBL from tolerant (nonthymectomized and thymectomized) animals (A) and naive (control) animals (B).

 
Phase 1 (priming phase, day 0–6) was as follows. Primed PBL were prepared in 24-well plates (Costar) using 4 x 106 PBL from tolerant animals (nonthymectomized or thymectomized) or from naive control SLAdd animals (naive2) cultured with 4 x 106 irradiated (25 Gy) donor-matched PBL (SLAgg) or third-party PBL (SLAhh or SLAaa) per well in a final volume of 2 ml of medium for 6 days at 37°C in 7.5% CO2. Bulk cultures were harvested, washed once in complete medium, and resuspended in fresh medium at 4 x 106 cells/ml. The effector cells were allowed to rest overnight at 37°C in 7.5% CO2 in 25-cm2 culture flasks (Costar) placed upright. The primed effectors (all of SLAdd genotype) produced are explained in Fig. 1Go, and included: 1) PBL from nonthymectomized swine tolerant to SLAgg renal allografts (non-thyxtolerant-to-G) or from thymectomized swine tolerant to SLAgg (thyxtolerant-to-G) primed with SLAgg PBL (non-thyxtolerant-to-G-G' and thyxtolerant-to-G-G', respectively) or with SLAhh PBL (non-thyxtolerant-to-G-H' and thyxtolerant-to-G-H'), respectively) (Fig. 1GoA, left), and 2) PBL from a naive swine (naive2) primed with SLAgg PBL (naive2-G') or with SLAhh PBL (naive2-H') (Fig. 1GoB, left). These primed effectors were cocultured in phase 2 as the regulator cells.

Phase 2 (coculture phase, day 7–13) was as follows. On day 7, fresh control MLC were prepared in 24-well plates (Costar) containing 2 x 106 naive SLAdd-responder PBL (naive1 PBL) and 4 x 106 irradiated stimulator PBL (donor-matched, SLAgg; or third-party, SLAhh) per well in a final volume of 2 ml of medium (Fig. 1GoA, right, lines 1 and 4; Fig. 1GoB, right, lines 1 and 4). The naive1 PBL were from a different source than the naive SLAdd PBL used in the priming phase (naive2). The naive1 PBL were used as indicator cells for the detection of suppression by the primed cells in coculture assays described below. The primed effectors from phase 1 were also harvested on day 7 and washed once in complete medium before being set up in the second phase. Control secondary MLC were performed using both primed effector groups prepared in the first phase stimulated in a secondary MLC with the same irradiated stimulator cells used in the priming phase (Fig. 1GoA, right, lines 2 and 5; Fig. 1GoB, right, lines 2 and 5). Cocultures contained 2 x 106 naive1 responder SLAdd PBL, 2 x 106 primed effector cells from phase 1, and 4 x 106 irradiated stimulator PBL per well in a final volume of 2 ml of medium (Fig. 1GoA, right, lines 3 and 6; Fig. 1GoB, right, lines 3 and 6). Control cultures for crowding effects were set up containing 4 x 106 naive1 responder PBL and 4 x 106 irradiated stimulator PBL, or 4 x 106 primed effectors from phase 1 and 4 x 106 irradiated stimulator PBL (not shown). Cultures in the second phase were incubated for 6 days at 37°C in 7.5% CO2 (day 7–13) and tested for cytotoxicity as described above. Target cells included PBL matched to the effectors (negative control) and PBL SLA-matched to the stimulators used in the first and second phase of the assay.

Modifications of the secondary coculture assay. To examine the mechanism of suppression, some of the primed effector groups prepared with PBL from tolerant and naive animals at the end of phase 1 were manipulated by the following methods before setting up phase 2. 1) Preparation of nonadherent and adherent cells. The primed effector group was divided into two groups. One group of cells (unseparated) was rested overnight by the usual method in 25-cm2 culture flasks (Costar) as described above. The second group of cells was incubated overnight at 37°C in 7.5% CO2 at 4 x 106 cells/ml in 75-cm2 flasks (Costar) lying down flat to allow maximal adherence of cells to the plastic surface. On day 7, nonadherent cells were harvested and washed. Adherent cells were harvested by gentle scraping and then washed. The adherent cells were estimated to be 10% of the original primed effector group. The unseparated, nonadherent, and adherent cell populations of primed effectors from phase 1 were then set up in coculture assays (phase 2). 2) Irradiation of the primed effectors. PBL from tolerant animals primed with SLAgg PBL in phase 1 were either nonirradiated or irradiated with 25 Gy before coculturing with the naive1 PBL. 3) Transwell assays. Primed effectors from tolerant recipients and naive1 PBL were cocultured in equal numbers as described above, either in the same well or separated by a semipermeable membrane (0.4 µm) in 6-well transwells (Costar). Cell cultures included: 2 x 106 naive1 PBL, 2 x 106 PBL from tolerant swine primed with SLAgg, and 4 x 106 SLAgg stimulators per well cocultured in the same well; 2 x 106 naive1 PBL and 4 x 106 SLAgg stimulators per well cultured in the bottom transwell, and 2 x 106 PBL from tolerant swine primed with SLAgg and 4 x 106 SLAgg stimulators per well cultured in the top transwell; 2 x 106 naive1 PBL and 4 x 106 SLAgg stimulators per well in the bottom transwell and medium only in the top transwell; 2 x 106 PBL from tolerant swine primed with SLAgg and 4 x 106 SLAgg stimulators per well in the top transwell and medium only in the bottom transwell. 4) Recombinant human IL-2 (Cetus, Emeryville, CA) was added in titrated concentrations (0–50 U/ml) to the anti-SLAgg-stimulated cocultures of naive1 PBL and PBL from tolerant swine primed with SLAgg PBL. Nonspecific cytotoxicity was assessed by testing on SLAhh in addition to SLAdd targets, and background killing was subtracted to determine the specific cytotoxicity.

Three-color flow cytometry

The following directly conjugated murine anti-pig mAb were used: anti-CD25 FITC-conjugated (mAb 231-3B2, mouse IgG1; 30 , anti-CD4 biotinylated (mAb 74-12-4, mouse IgG2b; 31 , anti-CD8 conjugated to phycoerythrin (PE; mAb 76-2-11, mouse IgG2a; 31 , anti-CD2 FITC-conjugated (mAb MSA-4, mouse IgG2a; 32 , anti-CD3 FITC-conjugated (mAb 2-6-15, mouse IgG2a; Lorf et al., manuscript in preparation), anti-class I FITC-conjugated (mAb 2-27-3a, mouse IgG1; 33 , anti-class II FITC-conjugated (mAb ISCR3/anti-DR, mouse IgG2b; 34 . mAb 36-7-5 (35) FITC-conjugated (anti-murine H2 Kk, mouse IgG2a) and anti-Leu3a PE (Becton Dickinson, San Jose, CA) were used as negative control Abs. For three-color flow cytometry analysis, the staining procedure was performed as follows: 1) 106 cells per tube were incubated with purified swine IgG for 10 min to block nonspecific binding of conjugated Abs; 2) the first incubation was directly FITC-labeled Ab; 3) after a single wash, the second Ab, which was directly PE-labeled, was added; 4) after a further wash, the final biotinylated Ab was added; 5) the biotinylated Ab was developed using cy-chrome-streptavidin (PharMingen, San Diego, CA), which was incubated for 8 min with washes before and after the addition of the cy-chrome-streptavidin. mAb incubations were performed on ice for 30 min. The data acquisition was performed on a FACScan (Becton Dickinson) and analyzed using the Winlist program (Verity Software, Topsham, ME). Four PBL subpopulations were defined by staining for CD4 and CD8 using separate colors: CD4 single positive (SP), CD4/8 double positive (DP), CD4/8 double negative, and CD8 SP PBL. Three-color flow cytometric analysis was performed by simultaneous staining of CD2, CD3, class I, class II, and CD25 with a third color.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
PBL from tolerant animals do not inhibit naive SLAdd anti-donor-matched (SLAgg) CTL responses in primary CML cocultures

Naive animals (positive control) showed strong anti-donor-matched (SLAgg) and anti-third-party CTL reactivity in primary CML responses (Fig. 2GoA). Both nonthymectomized and thymectomized tolerant animals demonstrated markedly lower antidonor CTL reactivity but maintained normal third-party responses (Fig. 2GoA). Unprimed PBL from tolerant swine were cocultured in a 1:1 ratio with naive SLAdd PBL to determine whether the hyporesponsive PBL from tolerant swine contained peripheral regulatory cells that could suppress the generation of CTL among naive T cells. Antidonor and anti-third-party CTL responses of naive animals were not suppressed in primary coculture assays with PBL from tolerant animals (compare Fig. 2GoB with the naive control responses in Fig. 2GoA, left).



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 2. Primary CTL responses (PSL results at E:T ratio 100:1) of naive animals, nonthymectomized tolerant animals, thymectomized tolerant animals, and primary coculture assays of PBL from naive animals with PBL from nonthymectomized or thymectomized tolerant animals. Results are shown as follows. A, Naive anti-SLAgg (n = 18) and anti-SLAhh (n = 18) responses (left), nonthymectomized anti-SLAgg (n = 5) and anti-third-party (SLAhh) (n = 5) responses (center), and thymectomized anti-SLAgg (n = 3) and anti-third-party (SLAaa n = 3) responses (right). B, Cocultures of PBL from naive animals with PBL from nonthymectomized tolerant animals stimulated by SLAgg or third-party (SLAhh) PBL (n = 2; left) or PBL from naive animals cocultured with PBL from thymectomized tolerant animals stimulated by SLAgg or third-party (SLAaa) PBL (n = 2; right). No suppression of naive responses was observed. The results represent the mean ± SD.

 
PBL from tolerant animals primed with donor Ag inhibited the generation of antidonor CTL reactivity by naive PBL

We hypothesized that regulatory cells from tolerant animals may require activation with donor Ag before any suppressive properties could be observed. Therefore, PBL from tolerant swine, or naive swine as controls, were prestimulated in culture for 6 days with donor Ag (SLAgg PBL). After the priming phase, the effector groups were then rested overnight, harvested, washed, and set up in coculture assays as outlined in Fig. 1GoA (lines 1 to 3) and Fig. 1GoB (lines 1 to 3). Naive1 was a second naive animal that would be used in the cocultures as indicator cells whose response might be suppressed by putative regulatory cells from the tolerant animals. Naive1 anti-SLAgg responses (Fig. 1GoA, line 1 and Fig. 1GoB, line 1) were the positive controls. The primed effector groups from the first phase were stimulated by SLAgg to determine the cytotoxicity of these effector groups alone (Fig. 1GoA, line 2 and Fig. 1GoB, line 2). Cocultures of the primed effectors with PBL from naive1 were performed to determine whether the anti-SLAgg responses by naive1 could be suppressed by the primed effectors (Fig. 1GoA, line 3 and Fig. 1GoB, line 3).

The pooled results for the anti-SLAgg responses in these assays are shown in Fig. 3Go. As expected, the naive1 PBL generated strong anti-SLAgg CTL reactivity when cultured alone (Fig. 3GoA). These were similar to the cytotoxic responses of the naive PBL controls in Fig. 2Go. When the primed effectors from phase 1 were stimulated a second time in phase 2 with SLAgg PBL, the non-thyxtolerant-to-G-G' and thyxtolerant-to-G-G' effector groups produced minimal antidonor CTL reactivity, while the naive2-G' effectors generated strong secondary anti-SLAgg cytotoxic responses (Fig. 3GoB). Primed non-thyxtolerant-to-G-G' and thyxtolerant-to-G-G' effectors suppressed naive1 anti-SLAgg CTL reactivity when these two groups of cells were cocultured (Fig. 3GoA vs Fig. 3GoC). In contrast to primed PBL from tolerant swine, naive2-G' effectors cocultured with naive1 PBL produced increased anti-SLAgg reactivity when compared with the cytotoxicity of each cocultured group alone (Fig. 3GoC). This result indicated that the ability to suppress CTL responses of naive cells was specific for the tolerant animals.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3. Anti-SLAgg cytotoxicity (PSL at E:T ratio of 100:1) in phase 2 of CTL assays. Nonthymectomized, thymectomized, and naive2 PBL were prestimulated for 6 days with SLAgg PBL in phase 1 (non-thyxtolerant-to-G-G', thyxtolerant-to-G-G', and naive-2G', respectively). In the second phase of the assay, anti-SLAgg CTL responses were determined for a second naive animal, naive1 (n = 14)(A); the prestimulated effector groups from phase 1: non-thyxtolerant-to-G-G' (n = 2), thyxtolerant-to-G-G' (n = 9), and naive-2G' (n = 3)(B); and cocultures of naive1 PBL with the primed effector groups: naive1 + non-thyxtolerant-to-G-G' (n = 2), naive1 + thyxtolerant-to-G-G' (n = 9), naive1 + naive2-G' (n = 3)(C). Results represent the mean ± SD.

 
As an additional control for specificity, simultaneous assays were set up using anti-third-party primed effector groups. PBL from tolerant and naive2 animals were primed for 6 days in culture with third-party PBL (SLAhh; Fig. 1GoA, left and Fig. 1GoB, left). In the second phase, naive1 anti-third-party responses were determined as positive control assays (Fig. 1GoA, line 4 and Fig. 1GoB, line 4). The primed effector groups from the first phase were stimulated by SLAhh to determine the cytotoxicity of the primed effector groups alone (Fig. 1GoA, line 5 and Fig. 1GoB, line 5). Cocultures of the primed effectors with naive1 were performed to determine whether the anti-SLAhh responses by naive1 were suppressed by the primed effectors (Fig. 1GoA, line 6 and Fig. 1GoB, line 6). The results of the anti-SLAhh stimulated responses are shown in Fig. 4Go. There was no inhibition of anti-SLAhh CTL responses when naive1 was cocultured with non-thyxtolerant-to-G-H' or thyxtolerant-to-G-H'or naive2-H' primed effectors (Fig. 4Go, A and B, vs C).



View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 4. Control anti-SLAhh cytotoxic responses (PSL at E:T ratio of 100:1) in phase 2 of CTL assays. Nonthymectomized, thymectomized, and naive2 PBL are prestimulated for 6 days with SLAhh PBL in the phase 1 (non-thyxtolerant-to-G-H', thyxtolerant-to-G-H', and naive-2H', respectively). In the second phase of the assay, anti-SLAhh CTL responses are determined for a second naive animal, naive1 (n = 10)(A); the prestimulated effector groups from phase 1: non- thyxtolerant-to-G-H' (n = 2), thyxtolerant-to-G-H' (n = 5), and naive-2H' (n = 3)(B); and cocultures of naive1 PBL with the primed effector groups: naive1 + non-thyxtolerant-to-G-H' (n = 2), naive1 + thyxtolerant-to-G-H' (n = 5), naive1 + naive2-H' (n = 3)(C). SLAaa stimulators were used in four assays for the thymectomized group and showed identical results (data not shown). Results represent the mean ± SD.

 
Cultures to determine whether primed non-thyxtolerant-to-G-G' or thyxtolerant-to-G-G' effectors could suppress naive1 anti-third-party reactivity (e.g.,{thyxtolerant-to-G-G' + naive1} anti-third-party response) were also performed. Controls for these cultures included determining whether naive2-G' effectors would suppress a second naive1 anti-third-party response (i.e., {naive1 + naive2-G'} anti-third-party response). These studies showed that non-thyxtolerant-to-G-G' or thyxtolerant-to-G-G' primed effectors were able to suppress naive1 anti-third-party reactivity partially and to variable degrees (data not shown). However, unlike the specific inhibition observed for antidonor reactivity above, this inhibition was also seen for naive2-G' primed effectors. Similarly, non-thyxtolerant-to-G-H', thyxtolerant-to-G-H', and naive2-H' primed effectors were able to variably suppress naive1 anti-SLAgg responses. These assays indicated that this suppression was nonspecific, and most importantly, was unrelated to the tolerant state induced in vivo. Previous reports of mice have demonstrated such nonspecific suppression of generation of CTL responses by alloactivated lymphocytes from naive mice (36). Since this kind of nonspecific suppression could be distinguished from the specific suppression in our assays, it was not further characterized.

In contrast, the suppression observed with PBL from tolerant animals primed with donor cells was specific for tolerant animals, and also specific for donor SLA Ag, provided the same stimulator was used in the priming phase and coculture phase of the assay (Figs. 3Go and 4Go). Therefore, subsequent experiments were focused on determining the mechanism of the regulatory response in these assays. For this purpose, the tolerant recipient that demonstrated the greatest degree of suppression (thymectomized animal 11446) was chosen for further study.

Suppression of naive PBL in coculture assays was cell-dose dependent

All coculture assays described above were performed with a naive SLAdd:thyxtolerant-to-G-G' PBL ratio of 1:1. In this analysis, the concentration of naive SLAdd PBL (2 x 106 cells/ml) was kept constant, and cocultured with primed thyxtolerant-to-G-G' PBL added at decremental concentrations (2 x 106 cells/ml to 0.001 x 106 cells/ml). Coculture of naive SLAdd PBL with primed thyxtolerant-to-G-G' effector PBL led to a titratable inhibition of the naive anti-SLAgg cytotoxic response (Fig. 5Go). Significant inhibition (>50% inhibition of the naive SLAdd antidonor cell response alone) was still observed at a thyxtolerant-to-G-G':naive SLAdd cell ratio of 1:4. At lower concentrations of the regulator cells, the inhibitory effect was not detectable.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 5. Inhibition of naive SLAdd anti-donor (SLAgg) CTL reactivity by primed thyxtolerant-to-G-G' PBL was cell-dose dependent. CTL reactivity is shown for the naive SLAdd (2 x 106 cells/ml) anti-SLAgg response alone. The same concentration of naive SLAdd PBL were cocultured with primed thyxtolerant-to-G-G' effectors at progressively decreasing concentrations: 2 x 106 cells/ml, 1 x 106 cells/ml, 0.5 x 106 cells/ml, 0.1 x 106 cells/ml, 0.01 x 106 cells/ml, and 0.001 x 106 cells/ml. The coculture results are labeled as the ratio of thyxtolerant-to-G-G' effectors:naive SLAdd PBL in each assay.

 
Suppression of CML reactivity is mediated by nonadherent, radiation-sensitive cells

Since previous studies suggested that miniature swine contain an adherent cell population with suppressive properties (37, 38), naive SLAdd PBL (2 x 106 cells/ml) were cocultured with unseparated thyxtolerant-to-G-G' PBL (2 x 106 cells/ml) or an adherent cell-depleted thyxtolerant-to-G-G' effector group (2 x 106 cells/ml) (Fig. 6Go). The nonadherent cell population completely inhibited the naive anti-SLAgg response. Ten percent of the primed thyxtolerant-to-G-G' effector group were adherent cells, and when this number of adherent cells (0.2 x 106 cells/ml) was cocultured with naive SLAdd responders, the naive anti-SLAgg response alone (PSL, 38.5%; E:T ratio, 100:1) was inhibited to a PSL of 25% (E:T ratio, 100:1). Therefore the suppressive effect was predominantly in the nonadherent cell population.



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 6. The nonadherent cell population contained most of the suppressive properties of the primed thyxtolerant-to-G-G' effector group. Naive SLAdd PBL (2 x 106 cells/ml) were cultured alone, cocultured with unseparated thyxtolerant-to-G-G' PBL (2 x 106 cells/ml), or cocultured with an adherent cell-depleted thyxtolerant-to-G-G' effector group (2 x 106 cells/ml). Complete inhibition of the naive anti-SLAgg CTL response was observed with the nonadherent cell population.

 
If the suppressive response required DNA synthesis during the cell cycle, one might predict that the regulatory cells would be inactivated by radiation. Therefore, the suppressive thyxtolerant-to-G-G' effectors were either untreated or irradiated with 25 Gy before coculture with the naive SLAdd PBL and stimulation by SLAgg PBL in the second phase of the CML assay (Fig. 7GoA). As controls, similar cultures were set up with thyxtolerant-to-G-H' effectors that were either untreated or irradiated with 25 Gy. The results showed that the nonirradiated thyxtolerant-to-G-G', cocultured with naive SLAdd PBL, inhibited the naive anti-SLAgg response as expected. However, the suppression was completely eliminated when the thyxtolerant-to-G-G' cells were irradiated before the coculture (Fig. 7GoA). In contrast, the anti-SLAhh cytotoxic response of the naive PBL alone and the thyxtolerant-to-G-H' primed effector group alone were augmented when the naive PBL were cocultured with thyxtolerant-to-G-H' (Fig. 7GoB). When the primed thyxtolerant-to-G-H' effectors were irradiated before the coculture (naive + thyxtolerant-to-G-H' 25 Gy), the cytotoxicity was similar to the cytotoxicity of the naive PBL alone.



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 7. Effect of irradiation on the suppressive effects. A, Anti-SLAgg CTL reactivity of naive effectors alone, thyxtolerant-to-G-G' effectors alone, naive PBL cocultured with nonirradiated thyxtolerant-to-G-G', and naive PBL cocultured with irradiated (25 Gy) thyxtolerant-to-G-G' effectors. B, Anti-SLAhh CTL reactivity of naive effectors alone, thyxtolerant-to-G-H' effectors alone, naive PBL cocultured with nonirradiated thyxtolerant-to-G-H', and naive PBL cocultured with irradiated (25 Gy) thyxtolerant-to-G-H' effectors.

 
Primed tolerant PBL require cell-to-cell contact to suppress antidonor CTL reactivity by naive SLAdd PBL

Separation of the naive SLAdd PBL and the primed thyxtolerant-to-G-G' cells by a semipermeable membrane that allowed soluble factors, but not cells, to pass through (6-well transwell chambers in culture plates) (Costar) was performed to distinguish the hypothesis that thyxtolerant-to-G-G' cells required cell-to-cell contact with the naive PBL to inhibit the generation of CTL as opposed to the possibility that soluble factors were involved in the mechanism of suppression. Thymectomized PBL were prestimulated for 6 days in phase 1 (thyxtolerant-to-G-G'), and subsequently, the following cultures were established in phase 2, as described in Materials and Methods: 1) naive PBL and SLAgg stimulators in the bottom chamber of the transwell and medium only in the top chamber, 2) thyxtolerant-to-G-G' and SLAgg stimulators in the top chamber of the transwell and medium only in the bottom chamber, 3) naive PBL cocultured with thyxtolerant-to-G-G' and SLAgg stimulators in the same well, and 4) naive PBL with SLAgg stimulators cultured in the bottom chamber of the transwell and thyxtolerant-to-G-G' with SLAgg stimulators cultured in the top chamber of the transwell. These were all cultured for 6 days, harvested, and tested for cytotoxicity. The results of one representative experiment are presented in Fig. 8Go. As expected, the naive PBL alone stimulated by SLAgg PBL generated strong anti-SLAgg cytotoxic responses, while thyxtolerant-to-G-G' alone stimulated by SLAgg PBL did not generate anti-SLAgg cytotoxic responses. Cocultures of naive PBL with thyxtolerant-to-G-G' and SLAgg stimulators in the same well led to complete suppression of the naive anti-SLAgg response as described above. However, separation of the naive and thyxtolerant-to-G-G' groups by a transwell restored the anti-SLAgg CTL response of the naive PBL to the level of the positive control (i.e., CTL response of the naive PBL cultured alone). These results indicated that cell-to-cell contact was required for the suppression of the naive PBL and that soluble factors were not able to mediate suppression between the transwell chambers. Control assays that examined anti-SLAhh responses of naive PBL alone, thyxtolerant-to-G-H' alone, and naive PBL cocultured with thyxtolerant-to-G-H' effector groups in the same well or across transwell membranes showed no evidence of suppression when cocultured in the same well, or across transwells (data not shown).



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 8. Inhibition of naive SLAdd anti-SLAgg CML reactivity by primed thyxtolerant-to-G-G' PBL requires cell-to-cell contact. Anti-SLAgg PSL is shown for: naive PBL and SLAgg stimulators in the bottom chamber of the transwell and medium only in the top chamber; thyxtolerant-to-G-G' and SLAgg stimulators in the top chamber of the transwell and medium only in the bottom chamber; naive PBL cocultured with thyxtolerant-to-G-G' and SLAgg stimulators in the same well, not separated by a membrane; and the naive PBL CTL response when naive PBL with SLAgg stimulators were cultured in the bottom chamber of the transwell, and thyxtolerant-to-G-G' with SLAgg stimulators cultured in the top chamber of the transwell.

 
Expression of IL-2R on the inhibitory effector group and effect of exogenous IL-2 on the suppressive response

One model for T cell-mediated suppression suggests that Ag-specific T cells that have been rendered anergic suppress other T cells with the same specificity by competing for IL-2 and for the Ag-presenting cell (8). If competition or absorption of IL-2 was a major mechanism of suppression, the {alpha}-chain of the IL-2R might be expected to be expressed at increased levels on the thyxtolerant-to-G-G' effectors stimulated by SLAgg at the end of phase 2, when compared with the control thyxtolerant-to-G-H' effectors stimulated by SLAhh. Flow cytometry demonstrated that thyxtolerant-to-G-G' anti-SLAgg effectors, which suppressed the generation of CTL by naive PBL, expressed lower levels of IL-2R {alpha}-chain (Fig. 9GoA) when compared with thyxtolerant-to-G-H' anti-SLAhh effectors, which did not demonstrate a suppressed response (Fig. 9GoB). The greatest difference in expression of IL-2R on the thyxtolerant-to-G-G' anti-SLAgg effectors and the thyxtolerant-to-G-H' anti-SLAhh effectors was observed in the CD8 SP cell population (Fig. 9Go, C vs D).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 9. Flow cytometry of the thyxtolerant-to-G-G' anti-SLAgg effector group (A) and the thyxtolerant-to-G-H' anti-SLAhh effector group (B) showing the IL-2R (CD25) expression on the x-axis and the relative cell number on the y-axis for each group. The CD25 expression is shown for the thyxtolerant-to-G-G' CD8 SP (C), CD4/8 DP (E), and CD4 SP (G) cells. Similarly the CD25 expression is shown for the thyxtolerant-to-G-H' CD8 SP (D), CD4/8 DP (F), and CD4 SP (H) cells. The percent represents the proportion of IL-2R-positive cells in each population of cells.

 
To further assess competition for IL-2 as a mechanism of suppression, exogenous IL-2 was added in titrating concentrations (0–50 U/ml) to anti-SLAgg responses of naive PBL alone, thyxtolerant-to-G-G' alone, and cocultures of naive PBL with thyxtolerant-to-G-G' effectors in which the naive PBL responses were inhibited. The addition of IL-2 at doses >5 U/ml produced nonspecific cytotoxicity (lymphokine-activated killer (LAK) cell) at the lower range of concentrations of IL-2 and induced complete unresponsiveness in naive anti-SLAgg CTL responses at the higher concentrations of IL-2. The unresponsiveness of the naive anti-SLAgg CTL responses with the addition of high doses of IL-2 was consistent with previous studies demonstrating that similar concentrations of IL-2 induced apoptosis and cell death of activated CD4 and CD8 T cells (39). Therefore, the optimal concentration of IL-2 that would allow interpretation of the results was determined to be <5 U/ml. However, the addition of <5 U/ml of IL-2 was not able to overcome the suppression of naive PBL when cocultured with the primed thyxtolerant-to-G-G' effector group (Fig. 10Go).



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 10. The effect of adding titrating concentrations of exogenous IL-2 to anti-SLAgg responses of naive PBL alone and cocultures of naive PBL with thyxtolerant-to-G-G' effectors. The responses of the thyxtolerant-to-G-G' alone was the same as the responses of the cocultures of naive PBL with thyxtolerant-to-G-G' effectors. The anti-SLAgg PSL responses are shown for cultures in which 0 U/ml, 0.75 U/ml, 1.0 U/ml, and 3.0 U/ml of IL-2 was added.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study was undertaken to determine the mechanism of tolerance to porcine class I mismatched renal allografts, and in particular, to test for the presence of peripheral regulatory cells. Since both thymectomized and nonthymectomized animals were shown to accept two haplotype class I mismatched renal allografts with a 12-day course of CyA (23, 26), both groups of animals were examined. While only nonthymectomized animals should be capable of utilizing central mechanisms of tolerance, it is likely that both thymectomized and nonthymectomized have similar peripheral mechanisms of tolerance. The results from the present study confirm that donor Ag-activated PBL from thymectomized and nonthymectomized recipients were able to inhibit the generation of antidonor CTL by PBL from naive animals. The thymectomized recipient was used for the further in vitro studies of the peripheral regulatory cells since these recipients are totally dependent on peripheral mechanisms of tolerance to maintain their allografts. The presence of such regulatory cells activated by donor Ag expressed by the allograft could confer local protection in vivo. The present study demonstrates that the regulatory cells require cell-to-cell contact to exert their suppressive effect, and this property would ensure that the immunoregulatory responses would be limited to sites where donor Ag and recipient donor-reactive T cells were present. We speculate that such cells may play an important role in the maintenance of tolerance in this preclinical large animal model of allograft transplantation and would have implications in the application of peripheral regulatory mechanisms of tolerance to clinical transplantation.

Results from previous studies indicated that local regulation or suppression may play a role in the maintenance of tolerance to class I mismatched renal allografts in miniature swine (24, 40). One study demonstrated that the administration of exogenous IL-2 ("help") during the induction of tolerance on postoperative day 8, 9, and 10, led to acute rejection of allografts, suggesting that a limitation of help was an important mechanism leading to the induction of tolerance (24). In contrast, the provision of exogenous IL-2 did not abrogate tolerance in long-term acceptors. Mechanisms of tolerance that may be operating in long-term tolerant swine includes deletion, anergy, or suppression of helper cells and/or CTL. Deletion or anergy of the antidonor helper cells in the maintenance period would lead to failure to activate antidonor CTL. However, since anti-donor precursor CTL are not deleted in long-term tolerant animals (40), the provision of exogenous IL-2 during the maintenance phase would be expected to abrogate tolerance. The findings in the present study support the alternative hypothesis that regulatory cells could inhibit the generation of CTL in vivo. Further studies are required to determine whether the regulation acts at the level of the helper cell or directly on the CTL. However, the concordance of the in vivo data demonstrating that exogenous IL-2 did not abrogate tolerance in long-term acceptors (24) and the in vitro findings that IL-2 was not able to overcome the suppression in vitro in the present study, argues against a deficiency of help as the major mechanism of tolerance in the maintenance phase of tolerance.

The presence of local regulatory cells is supported by studies of cocultures of graft-infiltrating cells from miniature swine that became spontaneously tolerant to single haplotype class I mismatched renal allografts. These cells were able to suppress antidonor CTL responses of naive T cells in vitro (41, 42). However, in contrast to the regulatory cells in the present study, the graft-infiltrating cells did not require preactivation in vitro to demonstrate their inhibitory effect in CML assays, probably because these cells were purified from a site where donor Ag was at high concentration (i.e., directly from the allograft).

Studies in miniature swine have indicated that PBL from tolerant and naive animals contain an adherent, non-T cell population that is able to nonspecifically suppress the generation of CTL (37, 38). The data in the present study demonstrate that the putative regulatory cells in primed PBL of tolerant swine were distinct from the suppressive adherent cell population described in the previous reports. Although a minimal degree of inhibition was evident in the adherent cell population, profound suppression of the naive antidonor response was observed in the nonadherent cell population (Fig. 6Go). A further differentiating property of the regulatory cells in the current study, compared with the adherent suppressive cells, was the complete inactivation of the inhibition by irradiating the thyxtolerant-to-G-G' effector group with 25 Gy (Fig. 7Go). The previous adherent suppressive cells were shown to be resistant to irradiation with 25 Gy but were sensitive to 50 Gy (37). The suppression observed with the adherent cell population was nonspecific and observed in naive (and tolerant) animals (43, 44), in contrast to the suppression observed in the present study in which the inhibition was demonstrated only in tolerant animals by priming PBL specifically with donor Ag. Since the tolerance in this large animal model is specific for donor Ag, it is likely that the nonadherent cells are more important than the adherent cells in the maintenance of tolerance.

Lysis of APCs in the stimulator cell population of the secondary cultures could induce apparent suppression by the primed tolerant-G' effector cells in phase 2 of the CTL assays. Although this possibility was not formally excluded, this would be an unlikely explanation since the suppressive primed non-thyxtolerant-to-G-G' and thyxtolerant-to-G-G' effector groups prepared in phase 1 (Fig. 1GoA, left) had negligible cytotoxic reactivity against SLAgg stimulators (e.g., anti-SLAgg PSL of 6.0% and 0.14% for two separate animals). In contrast, suppression of the naive PBL was not observed when nontolerant animals that generated marked anti-SLAgg CTL responses were the source of coculture primed cells in the secondary cultures.

Inhibition of naive PBL responders was not observed when cells were separated by transwells (Fig. 8Go). The transwell studies suggest that either soluble factors (e.g., cytokines) are not involved in the suppressive effect observed in vitro, or that soluble factors are operative but only when delivered at high concentrations, requiring cell-to-cell contact or close proximity of the regulatory cells with the donor reactive T cell. Alternatively, soluble factors may influence antidonor T cell responses by exerting their effects on the Ag-presenting cell. The presence of suppression in some models may result from differential secretion of T cell-derived cytokines by Th1 and Th2 cells (45, 46). Graft acceptance has been associated with a preferential shift toward a Th2 response, since Th2 cytokines are able to inhibit the Th1 program of cytokines (IL-2 and IFN-{gamma}) consistently observed in rejecting allografts (47, 48). Most attention has been focused on CD4+ Th1/Th2 cells, however similar patterns have been described for CD8+ cells (49). Studies from our laboratory support the speculation that regulatory cytokines are involved in the mechanisms leading to acceptance of class I mismatched renal allografts in miniature swine, since tolerant animals have high levels of IL-10 gene transcripts locally in the graft, while rejector animals express high levels of the IFN-{gamma} transcript (28). This cytokine pattern would be consistent with the differential activation of Th1 and Th2 cells in the tolerated allograft. Future studies will address the cytokine production by these primed regulatory cells, which could provide important information about soluble mediators of suppression.

Alternative mechanisms of tolerance may require cell-to-cell contact. Anergic T cells were shown to suppress Ag-specific T cells in vitro by competition for locally produced IL-2 and for the Ag-presenting cell (8). In the current study, prestimulation of PBL from tolerant animals with donor Ag may have induced anergy of antidonor T cells, and these anergic T cells were able to suppress the generation of CTL in the secondary cocultures. However, the hypothesis that inhibition could be mediated by anergic T cells expressing increased levels of IL-2R that absorbed IL-2 (8, 50) seems an unlikely explanation for the suppression observed in the present analysis. The inhibitory effector group, thyxtolerant-to-G-G' anti-SLAgg PBL, expressed relatively lower levels of IL-2R when compared with the nonsuppressive effector groups, thyxtolerant-to-G-H' anti-SLAhh (Fig. 9Go). Furthermore, anergy and suppression by anergic cells can generally be reversed by the addition of exogenous IL-2 (8). The inhibition by primed tolerant PBL could not be overcome by addition of exogenous IL-2. The non-thyxtolerant-to-G-G' and thyxtolerant-to-G-G' effectors could represent anergic cells that suppress naive PBL by competition for the Ag-presenting cell (8). The fact that the cell-dose dependency studies demonstrated that the inhibition was rapidly lost after the ratio of thyxtolerant-to-G-G':naive PBL was reduced to <1:4, and that cell-to-cell contact was required for the inhibition, is consistent with competition for ligand as a mechanism for the inhibition. A similar result would be achieved if the regulatory cells described in the current study were anti-idiotypic T cells (11), or veto cells (17, 18) that would require cell-to-cell contact to mediate their inhibitory effects.

Activation or maintenance of suppressor cells in mixed lymphocyte reactions has been described in rodent models (15, 51, 52, 53, 54). Regulatory cells generated from MLC were shown to prolong cardiac allograft survival when adoptively transferred in vivo using a rat model (53). Our miniature swine are inbred for the MHC but not for non-MHC loci. Inbreeding of a miniature swine line is currently underway, and adoptive transfer studies will be possible when the inbred line is established.

The data described in the present study is consistent with the hypothesis that regulatory cells are involved in the maintenance of tolerance to renal allografts in miniature swine, and concur with other studies from our laboratory suggesting that local suppressive factors are implicated in mechanism of tolerance (24, 40, 41, 42). Since the immunologic characteristics of miniature swine are similar to those of humans (20), isolation of the regulatory cells identified in the current report could provide important information for establishing donor-specific tolerance in clinical transplantation.


    Acknowledgments
 
We thank Drs. Megan Sykes, Hugh Auchincloss, David K. C. Cooper, and John Iacomini for their critical review of the manuscript; Lisa A. Bernardo for expert secretarial assistance; Kathy George for technical help; and Novartis for providing CyA.


    Footnotes
 
1 This work is supported by National Institutes of Health Grants A131046 and HL18646. Back

2 F.L.I. is a recipient of a Don and Lorrain Jacquot Travelling Fellowship awarded by the Royal Australasian College of Physicians and the Australian and New Zealand Society of Nephrology. Back

3 Address correspondence and reprint requests to Dr. David H. Sachs, Tranplantation Biology Research Center, Massachusetts General Hospital, MGH-East, Building 149-9019, 13th Street, Boston, MA 02129. Back

4 Abbreviations used in this paper: SLA, swine MHC; CyA, cyclosporin A; thyx, thymectomized; CML, cell-mediated lympholysis; PSL, percent specific lysis; naive-G', PBL from naive swine stimulated with SLAgg PBL; naive-H', PBL from naive swine stimulated with SLAhh PBL; PE, phycoerythrin; SP, single positive; DP, double positive; thyxtolerant-to-G-G', PBL from thymectomized swine tolerant to a SLAgg renal allograft stimulated with SLAgg PBL; thyxtolerant-to-G-H', PBL from thymectomized swine tolerant to a SLAgg renal allograft stimulated with SLAhh PBL. Back

Received for publication May 8, 1998. Accepted for publication September 8, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Charlton, B., Jr H. Auchincloss, C. G. Fathman. 1994. Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12:707.[Medline]
  2. Kappler, J. W., N. Roehm, P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.[Medline]
  3. Allen, P. M.. 1994. Peptides in positive and negative selection: a delicate balance. Cell 76:593.[Medline]
  4. Webb, S. R., J. Hutchinson, K. Hayden, J. Sprent. 1994. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. J. Immunol. 152:586.[Abstract]
  5. Jenkins, M. K., R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.[Abstract/Free Full Text]
  6. Schwartz, R. H.. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.[Abstract/Free Full Text]
  7. Schwartz, R. H.. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.[Medline]
  8. Lombardi, G., S. Sidhu, R. Batchelor, R. Lechler. 1994. Anergic T cells as suppressor cells in vitro. Science 264:1587.[Abstract/Free Full Text]
  9. Gershon, R. K., P. Cohen, R. Hencin, S. A. Liebhaber. 1972. Suppressor T cells. J. Immunol. 108:586.[Abstract/Free Full Text]
  10. Green, D. R., P. M. Flood, R. K. Gershon. 1983. Immunoregulatory T-cell pathways. Annu. Rev. Immunol. 1:439.[Medline]
  11. Lancaster, F., Y. L. Chui, J. R. Batchelor. 1985. Anti-idiotypic T cells suppress rejection of renal allografts in rats. Nature 315:336.[Medline]
  12. Asherson, G. L., V. Colizzi, M. Zembala. 1986. An overview of T-suppressor cell circuits. Annu. Rev. Immunol. 4:37.[Medline]
  13. Koide, J., E. G. Engleman. 1990. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. J. Immunol. 144:32.[Abstract]
  14. Bloom, B. R., P. Salgame, B. Diamond. 1992. Revisiting and revising suppressor T cells. Immunol. Today 13:131.[Medline]
  15. Pearce, N. W., A. Spinelli, K. E. Gurley, B. M. Hall. 1993. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2. Transplantation 55:374.[Medline]
  16. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, H. Waldmann. 1993. "Infectious" transplantationn tolerance. Science 259:974.[Abstract]
  17. Rammensee, H. G.. 1989. Veto function in vitro and in vivo. Int. Rev. Immunol. 4:175.[Medline]
  18. Heeg, K., H. Wagner. 1990. Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells. J. Exp. Med. 172:719.[Abstract/Free Full Text]
  19. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.[Medline]
  20. Sachs, D. H.. 1992. MHC homozygous miniature swine. M. M. Swindle, and D. C. Moody, and L. D. Phillips, eds. Swine as Models in Biomedical Research 3. Iowa State University Press, Ames.
  21. Gianello, P., J. M. Fishbein, D. H. Sachs. 1993. Tolerance to primarily vascularized allografts in miniature swine. Immunol. Rev. 133:19.[Medline]
  22. Gianello, P. R., D. H. Sachs. 1996. Effect of major histocompatibility complex matching on the development of tolerance to primarily vascularized renal allografts: a study in miniature swine. Hum. Immunol. 50:1.[Medline]
  23. Rosengard, B. R., C. A. Ojikutu, P. C. Guzzetta, C. V. Smith, III T. M. Sundt, K. Nakajima, S. M. Boorstein, G. S. Hill, J. M. Fishbein, D. H. Sachs. 1992. Induction of specific tolerance to class I disparate renal allografts in miniature swine with cyclosporine. Transplantation 54:490.[Medline]
  24. Gianello, P. R., G. Blancho, J. F. Fishbein, T. Lorf, V. Nickeleit, D. Vitello, D. H. Sachs. 1994. Mechanism of cyclosporine-induced tolerance to primarily vascularized allografts in miniature swine: effect of administration of exogenous IL-2. J. Immunol. 153:4788.[Abstract]
  25. Gianello, P. R., K. Yamada, J. M. Fishbein, T. Lorf, V. Nickeleit, R. B. Colvin, J. S. Arn, D. H. Sachs. 1996. Long term tolerance of primarily vascularized renal allografts in miniature swine: systemic tolerance versus graft adaption. Transplantation 61:503.[Medline]
  26. Yamada, K., P. Gianello, F. L. Ierino, T. Lorf, A. Schimizu, S. Meehan, R. B. Colvin, D. H. Sachs. 1997. Role of the thymus in transplantation tolerance in miniature swine. I. Requirement of the thymus for rapid and stable induction of tolerance to class I mismatched renal allografts. J. Exp. Med. 186:497.[Abstract/Free Full Text]
  27. Blancho, G., P. Gianello, S. Germana, M. Baetscher, D. H. Sachs, C. LeGuern. 1995. Molecular identification of porcine interleukin-10: regulation of expression in a kidney allograft model. Proc. Natl. Acad. Sci. USA 92:2800.[Abstract/Free Full Text]
  28. Blancho, G., P. R. Gianello, T. Lorf, S. Germana, I. Giangrande, G. Mourad, R. B. Colvin, D. H. Sachs, C. LeGuern. 1997. Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine. Transplantation 63:26.[Medline]
  29. Dallman, M. J., K. J. Wood, K. Hamano, A. R. Bushell, P. J. Morris, M. J. A. Wood, H. M. Charlton. 1993. Cytokines and peripheral tolerance to alloantigen. Immunol. Rev. 133:5.[Medline]
  30. Bailey, M., K. Stevens, P. W. Bland, C. R. Stokes. 1992. A monoclonal antibody recognizing an epitope associated with pig interleukin-2 receptors. J. Immunol. Methods 153:85.[Medline]
  31. Pescovitz, M. D., J. K. Lunney, D. H. Sachs. 1984. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J. Immunol. 133:368.[Abstract]
  32. Lunney, J. K., M. D. Pescovitz. 1987. Phenotypic and functional characterization of pig lymphocyte populations. Vet. Immunol. Immunopathol. 17:135.[Medline]
  33. Ivanoska, D., D. C. Sun, J. K. Lunney. 1991. Production of monoclonal antibodies reactive with polymorphic and monomorphic determinants of SLA class I gene products. Immunogenetics 33:220.[Medline]
  34. Watanabe, M., T. Suzuki, M. Taniguchi, N. Shinohara. 1983. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans. Transplantation 36:712.[Medline]
  35. Sachs, D. H., N. Mayer, K. Ozato. 1981. Hybridoma antibodies directed toward murine H-2 and Ia antigens. G. J. Hammerling, and U. Hammerling, and J. F. Kearney, eds. Monoclonal Antibodies and T Cell Hybridomas 95. North-Holland Biomedic, Elseview.
  36. Orosz, C. G., R. M. Ferguson. 1985. Suppression of in vitro CML generation by alloactivated lymphocytes: analysis of antigen-nonspecific suppressive mechanisms. J. Immunol. 134:45.[Abstract]
  37. Kortz, E. O., D. H. Sachs. 1989. Suppression of CML reactivity by non-T cells from miniature swine tolerant of a class I mismatched renal allograft. Curr. Surg. 46:107.[Medline]
  38. Sundt, T. M., J. S. Arn, D. H. Sachs. 1992. Patterns of T cell-accessory cell interaction in the generation of primary alloresponses in the pig. Transplantation 54:911.[Medline]
  39. Lenardo, M. J.. 1991. Interleukin-2 programs mouse {alpha}ß T lymphocytes for apoptosis. Nature 353:858.[Medline]
  40. Gianello, P. R., J. M. Fishbein, B. R. Rosengard, T. Lorf, D. M. Vitiello, J. S. Arn, D. H. Sachs. 1995. Tolerance to class I-disparate renal allografts in miniature swine: maintenance of tolerance despite induction of specific anti-donor CTL responses. Transplantation 59:772.[Medline]
  41. Rosengard, B. R., E. O. Kortz, P. C. Guzzetta, III T. M. Sundt, C. A. Ojikutu, R. B. Alexander, D. H. Sachs. 1990. Transplantation in miniature swine: analysis of graft-infiltrating lymphocytes provides evidence for local suppression. Hum. Immunol. 28:153.[Medline]
  42. Rosengard, B. R., C. A. Ojikutu, P. C. Guzzetta, C. V. Smith, III T. M. Sundt, K. Nakajima, S. M. Boorstein, G. S. Hill, D. H. Sachs. 1991. Renal transplantation in miniature swine: preliminary evidence that graft-infiltrating leukocytes suppress donor-specific cell-mediated lymphocytotoxicity in co-culture. Transplant. Proc. 23:189.[Medline]
  43. Weiss, A., F. W. Fitch. 1977. Macrophages suppress CTL generation in rat mixed leukoctye cultures. J. Immunol. 119:510.[Abstract/Free Full Text]
  44. Bernstein, D. C., G. M. Shearer. 1988. Suppression of human cytotoxic T lymphocyte responses by adherent peripheral blood leukocytes. Ann. NY Acad. Sci. 532:207.[Medline]
  45. Mosmann, T. R., R. L. Coffman. 1989. Heterogenicity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111.[Medline]
  46. Abbas, A. K., M. E. Williams, H. J. Burstein, T. L. Chang, P. Bossu, A. H. Lichtman. 1991. Activation and functions of CD4+ T cell subsets. Immunol. Rev. 123:5.[Medline]
  47. Nickerson, P., J. Steiger, X. X. Zheng, A. W. Steele, W. Steurer, P. Roy-Chaundhury, T. B. Strom. 1997. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance. Transplantation 63:489.[Medline]
  48. Piccotti, J. R., S. Y. Chan, A. M. VanBurskirk, E. J. Eichwald, D. K. Bishop. 1997. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?. Transplantation 63:619.[Medline]
  49. Kelso, A., A. B. Troutt, E. Maraskovsky, N. M. Gough, L. Morris, M. H. Pech, J. A. Thomson. 1991. Heterogenicity in lymphokine profiles of CD4+ and CD8+ T cells and clones activated in vivo and in vitro. Immunol. Rev. 123:85.[Medline]
  50. Lamb, J. R., E. D. Zanders, W. Sewell, M. J. Crumpton, M. Feldmann, M. J. Owen. 1987. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways. Eur. J. Immunol. 17:1641.[Medline]
  51. Salomon, D. R., D. J. Cohen, C. B. Carpenter, E. L. Milford. 1983. Regulation of the immune response to alloantigens: suppressor and helper T cells generated in the primary MLR of the rat. J. Immunol. 131:1065.[Abstract]
  52. Turka, L. A., E. L. Ramos, J. E. Leggat, E. L. Milford, P. A. Fraser, C. B. Carpenter. 1987. Antigen specificity of mixed lymphocyte response-induced suppressor cells. Hum. Immunol. 20:293.[Medline]
  53. Turka, L. A., K. Tanaka, J. W. Kupiec-Weglinski, E. L. Milford, N. L. Tilney, C. B. Carpenter. 1989. In-vivo activity of mixed lymphocyte response-generated suppressor cells and ability to prolong cardiac allograft survival in rats. Transplantation 47:388.[Medline]
  54. Bucy, R. P.. 1986. Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL-2 for activation. J. Immunol. 137:809.[Abstract]
  55. Ierino, F. L., K. Yamada, T. Lorf, J. S. Arn, D. H. Sachs. 1998. Mechanism of tolerance to class I-mismatched allografts in miniature swine: regulation of interleukin-2 receptor {alpha}-chain expression on CD8 peripheral blood lymphocytes of tolerant animals. Transplantation 66:454.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
A. D. Griesemer, J. C. LaMattina, M. Okumi, J. D. Etter, A. Shimizu, D. H. Sachs, and K. Yamada
Linked Suppression across an MHC-Mismatched Barrier in a Miniature Swine Kidney Transplantation Model
J. Immunol., September 15, 2008; 181(6): 4027 - 4036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Nobori, A. Shimizu, M. Okumi, E. Samelson-Jones, A. Griesemer, A. Hirakata, D. H. Sachs, and K. Yamada
Thymic rejuvenation and the induction of tolerance by adult thymic grafts
PNAS, December 12, 2006; 103(50): 19081 - 19086.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Abendroth, G. Morrow, A. L. Cunningham, and B. Slobedman
Varicella-Zoster Virus Infection of Human Dendritic Cells and Transmission to T Cells: Implications for Virus Dissemination in the Host
J. Virol., July 1, 2001; 75(13): 6183 - 6192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Baron, D. H. Sachs, and C. LeGuern
A Particular TCR {{beta}} Variable Region Used by T Cells Infiltrating Kidney Transplants
J. Immunol., February 15, 2001; 166(4): 2589 - 2596.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Yamada, K. Mawulawde, M. T. Menard, A. Shimizu, H. T. Aretz, J. K. Choo, K. S. Allison, J. K. Slisz, D. H. Sachs, and J. C. Madsen
MECHANISMS OF TOLERANCE INDUCTION AND PREVENTION OF CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE: THE EFFECT OF AUGMENTATION OF DONOR ANTIGEN LOAD
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 709 - 719.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. S. Lee, K. Yamada, K. L. Womer, E. P. Pillsbury, K. S. Allison, A. E. Marolewski, D. Geng, A. D. Thall, J. S. Arn, D. H. Sachs, et al.
Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses
J. Immunol., March 15, 2000; 164(6): 3434 - 3444.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ierino, F. L.
Right arrow Articles by Sachs, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ierino, F. L.
Right arrow Articles by Sachs, D. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Kidney Transplantation


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS